🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 97382D204 (prev. 254668502 )
- Market Cap
- Micro Cap
- Previous Symbol
- WINTD (changed 5/20/2020)
- Previous Name
- Discovery Laboratories, Inc.
Business: Windtree Therapeutics, Inc. is a global, clinical-stage, biopharmaceutical and medical device company with a mission to save and enhance the lives of patients by arming the healthcare providers who treat them with breakthrough therapies that satisfy significant unmet needs. Windtree is developing important acute care innovations in science and engineering and delivering them responsibly with unrelenting attention to quality and access to care.
Notes: April 28, 2020 -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced a 1-for-3 reverse stock split of its issued and outstanding common stock. The Company's common stock will begin trading on a split-adjusted basis at the opening of the OTCQB® Market on Wednesday, April 29, 2020 under the symbol "WINTD". After 20 trading days, the symbol will revert to WINT. An amendment to the Company's Amended and Restated Certificate of Incorporation to implement the reverse split stock was filed on April 28, 2020. January 22, 2016 -- Discovery Laboratories, Inc. (DSCO) will effect a one-for-fourteen (1-14) reverse split of its common stock. In conjunction with the reverse split, the CUSIP number will change to 254668502.
Company Contact
- CEO
- Jed Latkin
- CFO
- Jamie McAndrew
- Headquarters
- 2600 Kelly Road, Suite 100, Warrington, PA 18976
- Phone
- 215-488-9300
- Fax
- 215-488-9301
- Investor Relations
- Monique Kosse, LifeSci Advisors · 212-915-3820 · monique@lifesciadvisors.com